We describe the phenomenon of waning of focal hepatic all five patients. Of three patients treated with a second cycle and/or splenic lesions on abdominal computed tomographic of myeloablative chemotherapy, lesions again decreased in (CT) scan during neutropenia in patients with chronic distwo patients during neutropenia and increased again in one seminated candidiasis. After observation of the phenomepatient after neutrophil recovery. In all five patients, candidinon in one patient, a total of five cases were prospectively asis eventually resolved after prolonged antifungal treatmonitored with serial CT scans. After the diagnosis of disment. In chronic disseminated candidiasis, hepatic or splenic seminated candidiasis, hepatic lesions decreased in size and lesions may transiently disappear during neutropenia. Thus, conspicuousness in three patients, while in two others they antifungal therapy should not be discontinued on the basis disappeared completely during a subsequent chemotherof radiologic findings alone. apy-induced neutropenia. After recovery of the neutrophils, ᭧ 1997 by The American Society of Hematology. the lesions reappeared or increased in conspicuousness in cal and laboratory findings. Right upper abdominal discomfort was
T present in one patient, persistent fever after neutrophil recovery in three HE SYNDROME OF CHRONIC disseminated candidiasis (synonyms: hepatosplenic candidiasis, hepatic patients, elevated transaminases in two patients (maximum, 2.7 times candidiasis, focal hepatic candidiasis) is a well-described upper normal limit), elevated alkaline phosphatase level in four patients complication of prolonged neutropenia in patients treated (maximum, five times upper normal limit), and elevated C-reactive for hematologic malignancies. [1] [2] [3] [4] It is well known that focal protein level in all five patients (maximum, 16 times upper normal hepatic and/or splenic lesions become visible only when the limit). A tentative diagnosis was made when multiple round lesions in neutrophil count recovers. 1, 3 Here, we report five cases in the liver and/or the spleen were seen on a computed tomographic (CT) which these focal lesions not only appeared once neutrophils scan after recovery from prolonged severe neutropenia. In all patients, recovered, but then decreased or disappeared during subseconfirmation of diagnosis was attempted with a biopsy (Table 1) . Finequent phases of neutropenia.
needle aspiration of liver lesions confirmed the diagnosis of disseminated candidiasis in two cases: patient B had fungal pseudohyphae, MATERIALS AND METHODS while patient C had budding yeast forms visible on the smear. In four patients, laparoscopic biopsy of liver lesions was performed and Between January 1, 1989, and June 30, 1995, a total of 142 confirmed the diagnosis in another two patients (patients D and E). In patients with acute leukemia have been treated with myeloablative patient E, necrosis and budding yeast forms were found. In patients C chemotherapy at our institution. In 13 cases, a diagnosis of dissemiand D, inflammatory infiltrates consistent with candidiasis were seen. nated candidiasis with hepatic involvement was made when neutroAll aspirate and biopsy specimens were sent for fungal culture, none penia had resolved. In five of 13 patients, we were able to follow were found positive. prospectively the evolution of radiologic signs of hepatic and/or In summary, three patients (B, C, and E) had pathologic proof of splenic lesions during subsequent phases of neutropenia due to furthe diagnosis of candidiasis. In these three patients, antifungal therther myeloablative chemotherapy.
apy was initiated on the day of biopsy. One patient (D) had histologic Characteristics of these five patients are listed in Table 1 . Their evidence consistent with candidiasis. In this patient, antifungal therage ranged from 18 to 47 years. There were four women and one apy had been started 2 days before biopsy. In patient A, empirical man. Three patients had acute myelogenous leukemia (AML), while two had acute lymphoblastic leukemia (ALL). Disseminated candidiantifungal therapy was initiated at a time when no liver lesions asis was diagnosed after their first or second cycle of induction were evident, which may have contributed to the negative findings. chemotherapy and was not considered to be a contraindication to Specifically, fine-needle aspirations were performed 16, 34, and 72 continue myeloablative chemotherapy. After diagnosis of dissemindays and laparoscopic liver biopsy 77 days after amphotericin B had ated candidiasis, the patients underwent one or two further cycles been initiated. Diagnosis of candidiasis in patient A is based on the of myeloablative treatment ( throughout the procedure and thereafter for 6 months until the discollimation, 5 mm) volume scanning of the entire liver with a scan delay of 45 seconds in order to achieve good visualization of the portal continuation of all immunosuppressive therapy. At that time, both patients had normal CT scans (Table 2 ). Thus, these two patients enhancement phase. An oral contrast medium was administered 45 minutes before the examination for better visualization of bowel loops. lend support to the concept that disseminated candidiasis under fluconazole treatment is not a contraindication for alloBMT.
All CT images were evaluated prospectively by an experienced radiologist (G.P.K.) without knowledge of neutrophil counts. The sequence and duration of treatments in individual patients are listed in chronologic order in Table 1 . Outcome was excellent, withOncologic outcome is not the focus of this study, but is briefly mentioned here. Patient A was treated with alloBMT 1 year after out recurrence of fungal disease in all five cases.
CT examinations were performed using the helical technique (Sodiagnosis of AML in first complete remission (CR). Three years later, she is still in continued CR (CCR Abbreviation: NA, not applicable. * The organ with more visible lesions is listed first. † ''First cycle'' and ''second cycle'' refer to the first cycle and the second cycle after the diagnosis of hepatic candidiasis. The total number of chemotherapy cycles with prolonged neutropenia before and after the diagnosis of hepatic candidiasis is listed in Table 1 .
‡ ''During neutropenia'' refers to lesions on a CT scan performed while the patient was neutropenic. The number of days of severe neutropenia (õ500/mL) passed at the time the scan was performed is listed in parentheses. ''After neutropenia'' refers to lesions on a CT scan performed after recovery from severe neutropenia. The number of days from recovery of severe neutropenia (ú500/mL) until the scan was performed is listed in parentheses.
§ ''Long-term'' refers to the first CT scan on which all lesions had disappeared. The number of days from recovery of the last period of neutropenia until the scan was performed is listed in parentheses. Patients A and E underwent alloBMT 6 and 3 months after their last chemotherapy. For them, both the duration from the last chemotherapy-induced, as well as from alloBMT-induced neutropenia, is listed. In both patients, hepatic lesions were visible at admission for alloBMT and disappeared later. No CT scans were performed during alloBMT. Similarly, the number of days since recovery from severe RESULTS neutropenia (neutrophils ú500/mL) are listed in Table 2 . In Evolution of fungal lesions on CT scans during and after two of three patients treated with another cycle of myeloablaneutropenia is summarized in Table 2 . Figure 1 (patient A) tive chemotherapy, this waxing and waning pattern of radioand Fig 2 (patient B) serve to illustrate Table 2. logic lesions could be seen again (Fig 1D and E) . In all In three patients, multiple round lesions were seen on patients, lesions eventually disappeared ( Figs 1F and 2D ) postcontrast CT scans of the abdomen in the liver and the after prolonged antifungal therapy. spleen, while in two cases, lesions could only be seen in Two patients (A and E) underwent alloBMT before resoluthe liver (Table 2) . Following the diagnosis of disseminated tion of lesions and while still on antifungal treatment. For candidiasis, these lesions decreased in size and visibility logistic reasons, no CT scans were performed during the proceduring subsequent neutropenia in three patients (compare dure. It is noteworthy that in one patient (E), visible fungal Fig 2A and B) and disappeared completely in two patients lesions had disappeared at the end of alloBMT, while in the (compare Fig 1A and B) . The numbers of days of severe other patient (A), lesions disappeared 3 months later (Table 2) . neutropenia (neutrophils õ500/mL) at the time the CT scan DISCUSSION was performed are listed in Table 2 . After recovery from neutropenia and despite continued antifungal therapy, the This is the first report to describe the phenomenon of disappearance of hepatic and/or splenic lesions in chronic size and visibility of the lesions increased again (Fig 1C) . Similarly, we found that the lesions reappeared or increased neutropenia in a subsequent cycle of myeloablative therapy. When neutrophils recover, these lesions reappear. Thus, canagain at 7 to 46 days after neutrophil recovery. In two of three patients who underwent another cycle of myeloablative didiasis is still present and antifungal treatment needs to be continued. Therefore, for correct interpretation of the radiotreatment, a waxing and waning pattern of the visibility of radiologic lesions was documented. logic findings in disseminated candidiasis, they have to be correlated with the evolution of the neutrophil count.
AID

It has been shown by biopsy and autopsy studies that a focus of hepatic candidiasis becomes encircled and walled We have monitored five patients prospectively with repetitive abdominal CT scans during subsequent myeloablative off by neutrophils and other inflammatory cells. 3, 9 This is associated with better visibility and sometimes the typical treatments. We found that focal hepatic and/or splenic lesions disappeared or substantially decreased in size and contarget-type, bull's eye, or wheel-within-wheel appearance of lesions on imaging studies. 9 To our knowledge, the phenomspicuousness after 6 to 16 days of neutropenia (neutrophils õ500/mL). This observation is in concordance with the wellenon of decreasing visibility or disappearance of lesions during subsequent neutropenia has not been previously dedescribed phenomenon that these focal lesions become visi-AID (Fig 1A) , as well as the disease course with eventual total disappearance of lesions under antifungal the renewed absence of neutrophils might lead to a breakdown of the cellular containment of the fungus and allow treatment, was sufficient evidence to establish the diagnosis in patient A. for its reactivation and spread into adjacent tissues, thus blurring the boundary with neighbouring tissue. The clini-
In conclusion, in chronic disseminated candidiasis antifungal therapy should not be discontinued on the basis of imcian might be fooled to believe that he has eradicated the fungus, while in reality it is spreading. It is possible that aging studies alone and not before neutrophil recovery has occurred and lasted for a few weeks. other factors than neutropenia or a combination of host and fungal factors influence the visibility of the radiologic lesions. In our opinion, the observation of an undulating visi-tious effect. A more likely explanation for the disappearance 6. Anaissie E, Bodey GP, Kantarjian H, David C, Barnett K, Bow of lesions soon after alloBMT is that it was due to the simple 
